Pontin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pontin

Property Description
Active Ingredient Mefenamic Acid (C15H15NO2)
Form Capsule, Tablet (Oral, typically prescription-only)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Origin Synthetic, Anthranilic Acid Derivative
General Purpose Pain relief, inflammation reduction, fever lowering

Pontin is the trade name for a medication whose active ingredient is Mefenamic Acid, a synthetic compound clinically recognized for its pain-relieving and inflammation-reducing effects. It is categorically defined as a Nonsteroidal Anti-Inflammatory Drug (NSAID), placing it within a widely used class of analgesic, anti-inflammatory, and fever-reducing agents.


Classification and Active Ingredient Identity

Pontin is a single-active ingredient product where the therapeutic action is delivered exclusively by Mefenamic Acid. The drug belongs to the fenamate subgroup of NSAIDs, which are structurally classified as anthranilic acid derivatives. Unlike some other popular NSAIDs, Mefenamic Acid is pharmacologically noted for its pronounced analgesic action, particularly for acute pain conditions. The substance is categorized as a non-steroidal anti-inflammatory agent.


Form and General Purpose

Pontin is manufactured as solid oral dosage forms, typically available as capsules or film-coated tablets. The composition consists of the active Mefenamic Acid blended with necessary solid pharmaceutical excipients, which ensure the stability and proper systemic delivery of the medication.

The general purpose of Pontin is to provide symptomatic relief from acute discomfort by delivering three primary physiological actions: it is analgesic (pain-relieving), anti-inflammatory (inflammation-reducing), and antipyretic (fever-reducing). Mefenamic Acid has been utilized in the treatment of acute pain conditions. As such, the medication is intended for easing various forms of acute discomfort, such as generalized muscle aches or short-term inflammatory pain.

What side effects are possible with Pontin?

Possible Side Effects and Safety Information

Pontin, containing the Nonsteroidal Anti-Inflammatory Drug (NSAID) Mefenamic Acid, has a safety profile documented by regulatory agencies, with adverse reactions categorized by system and frequency.


Documented Adverse Reactions

The most frequently reported adverse reactions are generally related to the Gastrointestinal System, including diarrhea, abdominal pain, and nausea [FDA/SmPC]. Diarrhea is often documented as a dose-related event. Other organ systems potentially affected, as listed in regulatory labeling, include the Nervous System (headache, dizziness) and the Renal System (renal dysfunction).

Serious Safety Risks

Official prescribing information highlights the potential for serious adverse reactions. These include severe gastrointestinal events, such as ulceration, bleeding, and perforation, which can be fatal. The medication is also associated with an increased risk of serious cardiovascular thrombotic events, specifically myocardial infarction (heart attack) and stroke [FDA/DailyMed]. Rare, but serious, skin reactions like Stevens-Johnson syndrome (SJS) and Toxic epidermal necrolysis (TEN) are also documented [SmPC].

Population and Time-Related Safety Patterns

The risk of serious skin reactions is noted to be highest early in the course of therapy [SmPC]. Furthermore, the risk of cardiovascular events may increase with the duration of use [FDA]. Official labeling identifies specific populations with heightened risk: elderly patients have an increased frequency of adverse reactions, particularly fatal GI events. The drug is contraindicated in the third trimester of pregnancy and in individuals with severe renal or hepatic failure [FDA/SmPC].

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the potential manifestations and required emergency actions for overdose with Pontin (Mefenamic Acid).

Overdose may initially present with common signs such as nausea, vomiting, epigastric pain, lethargy, and drowsiness. However, severe outcomes are officially documented and require urgent attention. These serious complications can include central nervous system (CNS) toxicity, manifesting as convulsions, respiratory depression, and coma, as well as systemic effects like acute kidney failure and Gastrointestinal (GI) bleeding.

Required Emergency Actions

Immediate medical attention must be sought if an overdose is suspected or if any severe symptoms, such as altered consciousness or breathing difficulties, occur. The regulatory basis for management dictates that treatment must consist of symptomatic and supportive care.

Management Fact Regulatory Statement
Antidote Availability No specific antidotes are known or documented.
Supportive Measures Administration of activated charcoal and/or an osmotic cathartic may be indicated.
Ineffective Procedures Procedures like hemodialysis are generally considered not useful due to high plasma protein binding.
Population Risk Elderly patients are at an increased risk for severe complications like renal impairment, which can worsen overdose severity.

This required management strategy, combined with the lack of a specific antidote, mandates professional medical intervention when overdose is suspected.

Therapeutic Uses of Pontin

What Pontin Treats: Main Uses and Benefits

Pontin is used for managing symptoms related to physical discomfort, fever, and inflammation. The medication is applicable within clinical settings that involve acute or disruptive symptom patterns, and is relevant for easing challenging symptomatic manifestations.

The medication is commonly used across conditions presenting with acute episodes, offering supportive relief for pain stemming from various sources, including muscular aches, dental discomfort, and post-procedural soreness. It is also commonly used for managing the pain and cramping of primary dysmenorrhea and is relevant for easing fever (symptoms related to systemic imbalance).

“It helps address symptom clusters that appear suddenly or fluctuate during the menstrual cycle, supporting general well-being during symptomatic phases.”

Pontin assists with maintaining functional stability by helping to address symptoms that create noticeable physiological strain and contributes to improved comfort during periods of heightened discomfort.


Quick Fact: Relief for Episodic Discomfort Pontin is used in situations involving certain distressing symptoms, applied across therapeutic domains where short-term symptomatic assistance is needed for pain, inflammation, and fever.

Regulatory References

  1. NIH MedlinePlus overview on Mefenamic Acid

Eligibility and Restrictions for Use

Pontin (Mefenamic Acid) eligibility is strictly defined by regulatory documents, listing groups who are permitted to use the medicine and those who are expressly prohibited or restricted. The medication is approved for use in adults and adolescents geq 14 years of age.


Contraindicated Populations (Must Not Use)

Use is prohibited for patients with:

  • Known hypersensitivity to Mefenamic Acid or any other Nonsteroidal Anti-Inflammatory Drug (NSAID), including a history of NSAID-induced asthma or allergic reactions.
  • Active gastrointestinal ulceration, recurrent bleeding, or chronic inflammation of the GI tract (e.g., Inflammatory Bowel Disease).
  • Severe renal, hepatic, or cardiac failure.
  • Peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Age and Physiological Restrictions

Population Regulatory Status
Children < 14 years Not recommended; safety and efficacy are not established.
Elderly Patients Require caution and the lowest dose for the shortest duration due to increased risk of serious GI events.
Pregnancy Contraindicated in the last trimester (from 30 weeks gestation) and generally avoided from 20 weeks.
Breastfeeding Use is not recommended.

Patients with pre-existing conditions such as uncontrolled hypertension, impaired renal function (non-severe), or a history of heart failure must only use Pontin under conditional regulatory review.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Pontin (Mefenamic Acid) is based strictly on documented regulatory information, outlining pharmacokinetic and pharmacodynamic constraints with co-administered substances.

Documented Interaction Patterns

Interaction Type Interacting Agent(s) Regulatory Outcome
Bleeding Risk Reinforcement Oral Anticoagulants (e.g., Warfarin), Antiplatelet Agents, SSRIs, Corticosteroids Increases the risk of bleeding and gastrointestinal ulceration.
Altered Drug Clearance Lithium, Methotrexate Reduces renal clearance, leading to elevated plasma concentrations of the co-administered drug.
Efficacy Reduction ACE Inhibitors, ARBs, Diuretics Antagonizes the blood pressure-lowering or diuretic effect.
Absorption Alteration Antacids containing Magnesium Hydroxide Significantly increases the rate and extent of Mefenamic Acid absorption.

Mandatory Restrictions and Context

Official labeling contains specific prohibitions. Pontin is contraindicated for the management of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Co-administration with other systemic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is advised to be avoided due to increased gastrointestinal risk.

A mandatory timing requirement is established for Mifepristone, requiring Pontin to be avoided for 8 to 12 days following mifepristone administration to prevent a documented reduction in its efficacy. Co-consumption with alcohol also increases the officially stated risk of gastrointestinal adverse events.

Population-specific interaction notes indicate that the risk of acute renal failure when combining Pontin with ACE inhibitors or ARBs is heightened in patients with impaired renal function or the elderly.

Mechanism of Action

Inhibition of Eicosanoid Synthesis

The primary mechanism involves non-selective competitive inhibition of the Cyclooxygenase (COX) enzymes (COX-1 and COX-2). This action immediately arrests the conversion of arachidonic acid into various prostaglandins and other eicosanoids. The resulting reduction in prostaglandin levels dampens the chemical signaling that drives heightened inflammatory responses and fever, influencing the body's thermoregulatory and inflammatory processes.

Modulation of Peripheral Nociceptive Pathways

The drug's mechanism extends beyond enzyme blockade. It also features a direct antagonism of peripheral prostaglandin E₂ (PGE₂) receptors found on pain-sensing nerve endings. This combined approach of reduced mediator synthesis and direct receptor blockade is necessary for influencing nociceptive signaling at the periphery, resulting in a reduction of pain signal transmission.

Central Regulation of Thermogenesis

The COX inhibition extends to the central nervous system (CNS), specifically within the hypothalamus. Here, the drug restricts the synthesis of PGE₂, a key chemical mediator released in response to pyrogens. By reversing this chemical signal in the thermoregulatory center, the mechanism allows the body's elevated temperature set point to return to a baseline level, initiating a physiological sequence of heat dissipation.

Dosage and Administration Information

How to Use Pontin: Official Administration Guidelines

Pontin, which contains the active ingredient Mefenamic Acid, is administered according to specific established protocols. These guidelines address the authorized route, dosing schedules, and duration constraints.


Official Administration Protocol

Feature Official Instruction
Route of Administration Oral (by mouth) via capsules or tablets.
Intake Condition Must be taken with food or milk to aid proper intake.
General Principle Use the lowest effective dose for the shortest duration necessary.

Standard Dosing Regimens

The standard protocol for adults and adolescents 14 years of age and older is structured in two parts:

  • Initial Dose: 500 mg (a loading dose taken at the onset of symptoms).
  • Maintenance Dose: 250 mg every six hours (q6hr), taken as needed.

Duration Limits and Population Constraints

The medication is categorized for short-term use and should not be used as a long-term treatment option.

  • Acute Pain: Use should not exceed 7 days.
  • Primary Dysmenorrhea (Menstrual Pain): Use is generally not necessary for more than 2 to 3 days and should begin at the onset of bleeding and associated pain.
  • Age Restriction: Pontin is not recommended for children under 14 years of age for the approved acute indications. Older adults require careful monitoring, and the lowest effective dose should be used due to increased sensitivities.

Recent Clinical Evidence

The research base for Pontin (Mefenamic Acid) is built upon studies exploring short-term symptom management, particularly for acute pain and primary dysmenorrhea. The available evidence was evaluated in highly structured Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews that monitor patient-reported outcomes.


Evidence for Use in Acute Pain Conditions

Research involving Pontin was studied for conditions characterized by episodic or acute changes in pain levels, such as pain following dental procedures. These trials explored outcomes related to physical discomfort and monitored patient-reported outcomes over defined, short time intervals, typically 4 to 6 hours. Findings describe patterns observed where the groups receiving the medication documented different patterns of change in pain scores between the study groups. Research also monitored the requirement for rescue analgesic medication. The results apply only to the populations studied, and evidence for chronic or long-term pain is limited.


Evidence for Use in Primary Dysmenorrhea

Pontin was evaluated in studies focusing on primary dysmenorrhea, a condition characterized by periods of heightened symptoms such as pain and cramping. Investigations include multiple RCTs that monitored patient-reported outcomes describing perceived discomfort and symptom intensity. Studies reported how symptoms evolved in the observed populations, documenting different patterns of pain and cramping between the study groups. Research exploring short-term symptom patterns typically focuses on treatment delivered over a few days per cycle, and provides limited insight into long-term symptom management.


Consistency of Findings and Research Gaps

The research structure for Pontin is predominantly focused on acute relief. Studies exploring short-term symptom changes typically utilize follow-up durations that were limited, often to a maximum of 7 days for general acute pain. Consequently, long-term effects are not fully established, and data for certain groups remain insufficient, particularly for older adults or individuals with complex underlying health issues. Research highlights what is known — and what is still uncertain — regarding long-term outcomes and evidence consistency.

Key Studies & References Mefenamic Acid (NIH MedlinePlus Overview)

Frequently Asked Questions (FAQ)

Common questions about Pontin (FAQ)

Q: Is Pontin safe to take if I have liver problems?

A: According to official prescribing information, Pontin is contraindicated and described as not for use in individuals with severe hepatic failure (severe liver problems). Official information indicates that patients with any existing liver dysfunction typically require careful monitoring by a healthcare professional.

Q: Is Pontin the same as other similar-sounding drugs?

A: Pontin is the brand name for the active ingredient Mefenamic Acid. It belongs to the fenamate group within the Nonsteroidal Anti-Inflammatory Drug (NSAID) class. While other medicines belong to the same drug class, Mefenamic Acid is the distinct single active ingredient in Pontin.

Q: Can Pontin cause light sensitivity or skin reactions?

A: Official drug safety information documents the potential for rare, serious skin reactions, such as Stevens-Johnson syndrome (SJS). Less severe reactions, including an increase in the skin's sensitivity to sunlight (known as photosensitivity), have also been documented in official side effect listings.

Q: Does Pontin interact with alcohol?

A: Regulatory documents explicitly state that combining Pontin with alcohol increases the risk of gastrointestinal adverse events. This interaction specifically increases the officially stated risk of stomach bleeding and is advised to be avoided in official documentation.

Q: Is Pontin a controlled substance?

A: Pontin is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). The drug is not currently scheduled or regulated under the U.S. Controlled Substances Act.

Q: Does Pontin carry a Boxed Warning from the FDA?

A: Yes, as a systemic NSAID, the medication is required by regulatory mandate to carry a Boxed Warning in its official labeling. This warning highlights the potential for serious cardiovascular risks, such as heart attack and stroke, and serious gastrointestinal events, like bleeding or ulceration.

Q: Are headaches a common side effect of Pontin?

A: Regulatory documents list headache as an adverse reaction affecting the nervous system. While side effects like diarrhea and abdominal pain are often cited as the most frequent, headache is included in the list of commonly reported, non-serious reactions.

Q: How quickly should Pontin start working?

A: Pontin is rapidly absorbed after it is taken by mouth. Based on official pharmacokinetic data, the mean peak plasma level, which represents the highest concentration of the drug in the bloodstream, is generally reached within two to four hours after a single dose.

Q: Can Pontin make me feel sleepy or tired?

A: Official drug safety information documents that the medication may cause central nervous system side effects. These reactions include both drowsiness (somnolence) and feelings of unusual tiredness or weakness (fatigue).

Q: What happens if I forget to take a dose of Pontin?

A: Regulatory patient information often describes taking the missed dose as soon as it is remembered. However, if it is close to the time of the next scheduled dose, skipping the missed dose and resuming the regular schedule is often described. Regulatory guidance states that double or extra doses should not be taken to make up for a missed dose.

Q: Are there any foods or drinks I should avoid while taking Pontin?

A: The official instructions advise that the medicine must be taken with food or milk to aid proper intake. It is also advised to avoid consuming alcohol due to the heightened risk of gastrointestinal bleeding. No other specific food groups or common drinks are typically restricted in the regulatory labeling.

Q: Can I take Pontin if I am already taking supplements?

A: Official product information lists specific, known interactions with certain prescription medications. Official documentation notes the importance of providing a healthcare provider with information about all co-administered substances, including supplements, to allow for the proper screening of potential interactions.

Q: Can Pontin cause weight changes?

A: Regulatory labeling advises patients to be alert for symptoms that may indicate serious cardiovascular issues, such as congestive heart failure. These symptoms can include unexplained weight gain or the development of edema (swelling). The presence of these symptoms is documented as a reason to seek review from a healthcare professional.

Q: Does Pontin need to be refrigerated or stored in a special way?

A: Official storage instructions require the medicine to be kept at a controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). The medication is not required to be refrigerated. It must also be stored in its original, tightly closed container, protected from moisture and excessive heat.

Q: Will taking Pontin affect my ability to drive or operate machinery?

A: Because the medication can cause central nervous system side effects, such as dizziness and drowsiness, official counseling describes the need for caution when performing certain tasks. Patients are advised to assess their reaction to the medication before engaging in tasks that require mental alertness, such as driving or operating heavy machinery.

Q: How long does Pontin stay in the body?

A: The rate at which the drug is eliminated from the body is measured by its half-life. The elimination half-life of Mefenamic Acid is approximately two hours. This means that it takes roughly two hours for the body to eliminate half of the drug present in the system.

Q: Can Pontin affect my blood pressure?

A: Official drug warnings indicate that NSAIDs, including Pontin, should be used with caution in patients with existing hypertension (high blood pressure). Official documents emphasize the need for close monitoring of blood pressure when the medicine is initiated and continued in this population.

Q: Can I use Pontin if I have a history of kidney stones?

A: While specific conditions like kidney stones are not explicitly addressed, the medication is contraindicated in severe renal failure and should be used with caution in patients with any pre-existing kidney disease. Official information indicates that individuals with a history of kidney issues typically require close monitoring by a healthcare professional.

Q: Can taking Pontin make me feel anxious or dizzy?

A: Regulatory documents list dizziness as a documented side effect affecting the nervous system. The official safety profile also includes less common reactions like nervousness and confusion. However, the specific term anxiety is not explicitly listed in the documented adverse reactions.

Q: Can Pontin be broken in half or crushed?

A: Pontin is manufactured as solid oral dosage forms, such as capsules or tablets. Unless the product's official labeling or a healthcare professional specifically indicates that it is safe to alter the form, the medication is generally described as needing to be swallowed whole.

Q: What should I do if I suspect an interaction between Pontin and another drug?

A: Official patient counseling information notes that seeking prompt medical attention is necessary if signs or symptoms of a serious adverse event or suspected drug interaction are experienced. Examples of serious symptoms include chest pain, shortness of breath, slurring of speech, or any signs of internal bleeding.

Q: Does Pontin interact with birth control pills?

A: While the FDA label does not list a general interaction with all hormonal contraceptives, it advises caution when Pontin is combined with certain oral contraceptives containing drospirenone. This combination may increase the risk of elevated potassium levels in the blood.

Q: Does Pontin have any known effects on fertility?

A: For females of reproductive potential who are attempting to become pregnant, the official labeling advises that NSAIDs, including Pontin, may be associated with a reversible delay in ovulation. This effect is a documented consideration for use in this population.

How should Pontin be stored and disposed of?

How to Store and Dispose of Pontin?

Pontin (Mefenamic Acid) must be stored and disposed of according to official regulatory labeling to ensure its stability and prevent accidental exposure.

Official Storage and Handling

The medicine requires storage at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The container must be kept tightly closed and be light-resistant, protecting the medication from moisture and excessive heat. For child safety, the medication must always be stored securely, out of the sight and reach of children.

Disposal Requirements

Unused or expired Pontin should be disposed of using an authorized drug take-back program. It is prohibited to flush the medication down the toilet or pour it into a drain; disposal must follow local governmental regulations. If a take-back option is unavailable, the medication can be mixed with an undesirable substance, placed in a sealed bag, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pontin found in:

A-Z Index: